{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T11:51:55Z","timestamp":1778500315694,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["108-2314-B-384-004"],"award-info":[{"award-number":["108-2314-B-384-004"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.prp.2023.155059","type":"journal-article","created":{"date-parts":[[2023,12,24]],"date-time":"2023-12-24T06:40:32Z","timestamp":1703400032000},"page":"155059","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Clinicopathological and genetic landscape of plasmablastic lymphoma in Taiwan"],"prefix":"10.1016","volume":"253","author":[{"given":"Bo-Jung","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung-Han","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Tsu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren Ching","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Fen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Yu","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Zhen","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Han","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Hsing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Sung","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2023.155059_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/bjh.13562","article-title":"Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cells","volume":"171","author":"Evans","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.prp.2023.155059_bib2","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.prp.2023.155059_bib3","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/PAS.0000000000000234","article-title":"Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases","volume":"38","author":"Morscio","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.155059_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/PAP.0000000000000253","article-title":"Lymphoid neoplasms with plasmablastic differentiation: a comprehensive review and diagnostic approaches","volume":"27","author":"Chen","year":"2020","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.prp.2023.155059_bib5","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/PAS.0b013e31826cb1d1","article-title":"Plasmablastic transformation of low-grade B-cell lymphomas: report on 6 cases","volume":"37","author":"Martinez","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.155059_bib6","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/PAS.0b013e3181f3e29f","article-title":"IG\/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas","volume":"34","author":"Valera","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.155059_bib7","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/modpathol.2010.72","article-title":"Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features","volume":"23","author":"Taddesse-Heath","year":"2010","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2023.155059_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/modpathol.2016.162","article-title":"Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1","volume":"30","author":"Montes-Moreno","year":"2017","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2023.155059_bib9","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1038\/s41467-021-25405-w","article-title":"Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma","volume":"12","author":"Frontzek","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2023.155059_bib10","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.3324\/haematol.2020.271957","article-title":"MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma","volume":"106","author":"Ramis-Zaldivar","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.prp.2023.155059_bib11","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1182\/bloodadvances.2021005486","article-title":"Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways","volume":"6","author":"Witte","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.prp.2023.155059_bib12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3324\/haematol.2020.267294","article-title":"Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas","volume":"107","author":"Leeman-Neill","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.prp.2023.155059_bib13","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3324\/haematol.2020.251579","article-title":"Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma","volume":"106","author":"Garcia-Reyero","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.prp.2023.155059_bib14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1158\/2643-3230.BCD-20-0051","article-title":"Genomic characterization of HIV-associated plasmablastic lymphoma identifies pervasive mutations in the JAK-STAT pathway","volume":"1","author":"Liu","year":"2020","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.prp.2023.155059_bib15","unstructured":"S. Montes-Moreno, L. Leoncini, R. Miranda, J. Abner Louissaint, M. Sengar2022 Plasmablastic lymphoma, in: G. Ott, D. de Jong, S.S. Dave (Eds.), WHO Classification of Tumours Editorial Board. Haematolymphoid tumours [Internet; beta version ahead of print], Lyon (France): International Agency for Research on Cancer; [cited 2023 Sep. 12th], (WHO classification of tumours series, 5th ed.; vol. 11). Available from: \u3008https:\/\/tumourclassification.iarc.who.int\/chapters\/63\u3009."},{"key":"10.1016\/j.prp.2023.155059_bib16","unstructured":"S. Kumar, L.J. Medeiros, S. Gujral, K.N. Naresh, M. Lim, B. Walker, P. Malhotra, R. Gupta, A. Karadimitris, S.V. Rajkumar, A.J. Cowan, B. Paiva D. Maruyama, L.B. Baughn, Plasma cell myeloma \/ multiple myeloma, in: W.J. Chng, W.A. Sewell, H. Nagai (Eds.), WHO Classification of Tumours Editorial Board. Haematolymphoid tumours [Internet; beta version ahead of print], Lyon (France): International Agency for Research on Cancer; 2022 [cited 2023 Sep. 12th], (WHO classification of tumours series, 5th ed.; vol. 11). Available from: \u3008https:\/\/tumourclassification.iarc.who.int\/chapters\/63\u3009."},{"key":"10.1016\/j.prp.2023.155059_bib17","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(15)01281-7","article-title":"Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial","volume":"387","author":"Herbst","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2023.155059_bib18","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.jtho.2021.05.001","article-title":"Five YEar Survival Update From KEYNOTE-010: Pembrolizumab versus docetaxel for previously treated, programmed death-ligand 1-positive advanced NSCLC","volume":"16","author":"Herbst","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.prp.2023.155059_bib19","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1038\/srep02650","article-title":"Comprehensive identification of mutational cancer driver genes across 12 tumor types","volume":"3","author":"Tamborero","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2023.155059_bib20","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2023.155059_bib21","article-title":"Plasmablastic lymphoma: review of 60 Chinese cases and prognosis analysis","volume":"96","author":"Han","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.prp.2023.155059_bib22","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/10428190902789173","article-title":"Human immunodeficiency virus-negative plasmablastic lymphoma in Korea","volume":"50","author":"Kim","year":"2009","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.prp.2023.155059_bib23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1600-0714.2008.00673.x","article-title":"Minimum diagnostic criteria for plasmablastic lymphoma of oral\/sinonasal region encountered in a tertiary cancer hospital of a developing country","volume":"38","author":"Kane","year":"2009","journal-title":"J. Oral. Pathol. Med."},{"key":"10.1016\/j.prp.2023.155059_bib24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00428-022-03342-3","article-title":"Plasmablastic myeloma in Taiwan frequently presents with extramedullary and extranodal mass mimicking plasmablastic lymphoma","volume":"481","author":"Chen","year":"2022","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2023.155059_bib25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41408-021-00493-5","article-title":"Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing","volume":"11","author":"Gebauer","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.prp.2023.155059_bib26","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2017-11-814913","article-title":"Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma","volume":"131","author":"Tiacci","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.prp.2023.155059_bib27","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1182\/blood.2019002067","article-title":"Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade","volume":"134","author":"Chapuy","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.prp.2023.155059_bib28","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1038\/s41375-018-0037-9","article-title":"Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups","volume":"32","author":"Bolli","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.prp.2023.155059_bib29","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1038\/s41467-019-11680-1","article-title":"Genomic landscape and chronological reconstruction of driver events in multiple myeloma","volume":"10","author":"Maura","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2023.155059_bib30","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.prp.2023.155059_bib31","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3389\/fonc.2018.00550","article-title":"The NOTCH pathway and its mutations in mature B cell malignancies","volume":"8","author":"Arruga","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2023.155059_bib32","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/modpathol.3800355","article-title":"Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles","volume":"18","author":"Vega","year":"2005","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2023.155059_bib33","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/s41467-019-09555-6","article-title":"Multiple myeloma immunoglobulin lambda translocations portend poor prognosis","volume":"10","author":"Barwick","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2023.155059_bib34","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1309\/AJCPUIDW2CPTA1JA","article-title":"Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases","volume":"143","author":"Al-Kawaaz","year":"2015","journal-title":"Am. J. Clin. Pathol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823007604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823007604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T11:55:25Z","timestamp":1730894125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823007604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":34,"alternative-id":["S0344033823007604"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.155059","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathological and genetic landscape of plasmablastic lymphoma in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.155059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155059"}}